CLASS II ONGOING Drug recall · Reported 13 May 2026 · FDA Enforcement Report

TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume recalled

Central Admixture Pharmacy Services, Inc (Caps) Los Angeles is recalling TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume per, distributed in California. The recall was initiated on 27 Dec 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 11-4909703-0-1, Exp 12/28/2025
Quantity recalled1 bag

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0524-2026
FDA event ID
98831
Classification
Class II
Status
Ongoing
Recall initiated
27 Dec 2025
FDA classified
7 May 2026
Reported
13 May 2026
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Packaging Defects

Timeline

27 Dec 2025Recall initiated by company
7 May 2026Classified by FDA+131 days
13 May 2026Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Incorrect Product Formulation: product did not contain insulin as listed in the label.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90670

Where it was distributed

CA

California

Questions about this recall

Why was it recalled?

Incorrect Product Formulation: product did not contain insulin as listed in the label.

Which lots are affected?

Lot #: 11-4909703-0-1, Exp 12/28/2025

Where was it sold?

CA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Central Admixture Pharmacy Services, Inc (Caps) Los Angeles

All 2